glp-1 news 2025 october 21 Pipeline Update: May - Prime Therapeutics GLP-1 Agonists Market Report 2025-2033,

Front endocrinology

doi: 10.2133/dmpk.24.53 [DOI] [PubMed] [Google Scholar] 226.Rowland M, Peck C, Tucker G

For patients like Sarah, this therapy can deliver substantial improvements in weight, blood sugar control, and overall quality of life

To test how probiotics help with metabolic disorders, scientists examine factors such as cholesterol levels, liver fat, liver enzymes, and genes or proteins related to inflammation

Following 1:1 propensity score matching, both the GLP-1 RA user and non-user groups included 183,264 patients

When I asked about this and how Agile can still offer these medications after the FDA ban, an Agile customer service agent told me: We do offer compounded GLP-1s